HOME STORY OF OUR FIRM SEARCH
ASBESTOS DRUGS POLLUTANTS ACCIDENTS MALPRACTICE
English En Français

FREE LEGAL REVIEW

First Name
Last Name
Home Phone
Work Phone
City and State
Email
Were you diagnosed with Asbestosis? Yes
No
Were you diagnosed with lung cancer? Yes
No
Were you diagnosed with Mesothelioma? yes
no
What is your date of diagnosis?
Additional Comments
Best time to call?

Clinical Trial for Mesothelioma Patients: Antineoplaston Therapy Program Objectives

Read the program objectives for this current clinical trial being conducted to study the effects of Antineoplaston therapy program for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only.

Primary Outcome Measures:
Response rate based on tumor measurements taken at 12 weeks [ Designated as safety issue: No ]

Secondary Outcome Measures:
Survival at 1, 2, and 5 years from the start of treatment [ Designated as safety issue: No ]

Recruitment Information:
Recruitment Status: Recruiting
Enrollment: 40
Study Start Date: March 1996 through December 2011 (Final data collection date for primary outcome measure)

Objectives:
Provide treatment with antineoplastons A10 and AS2-1 to patients with stage IV mesothelioma.
Describe the response to, tolerance to, and side effects of this regimen in these patients.

Outline: Patients receive gradually escalating doses of antineoplaston A10 and antineoplaston AS2-1 IV six times per day until the maximum dose is reached. Treatment continues for at least 3 months in the absence of disease progression or unacceptable toxicity. After 3 months, patients with stable or responding disease may continue treatment. Patients achieving complete response (CR) continue treatment for at least 8 months beyond CR. Patients are followed every 2 months for 1 year and then every 3 months for the second year.

Courtesy of ClinicalTrials.gov.

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney

Mesothelioma Mesothelioma Home Page
head Mesothelioma: An Overview
kleio The Clock Is Ticking
asbestos Our Toughest Cases
head Diagnosis
treatment Symptoms, Stages, Treatment
kleio Latest News
New York Numbers
Asbestos


IN THIS SECTION
Antineoplaston trial for mesothelioma patients
Antineoplaston clinical trial for mesothelioma
Antineoplaston therapy for mesothelioma patients
Antineoplaston test for mesothelioma patients


RETURN BACK TO
Mesothelioma
Treatment of Mesothelioma
Treatment
Clinical trials on asbestos illness: mesothelioma

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING

see also:

Antineoplaston therapy for mesothelioma patients Therapy program to treat mesothelioma patients with Antineoplaston
Read about Antineoplaston therapy program for mesothelioma patients

Antineoplaston trial for mesothelioma patients Clinical trial to treat mesothelioma patients with Antineoplaston
Objectives for mesothelioma patients in Antineoplaston clinical trial

Antineoplaston therapy for mesothelioma patients Clinical trial of Antineoplaston therapy for mesothelioma patients
Antineoplaston may inhibit cancer cell growth in mesothelioma patients